Yan Li is currently the Sr. Director of Clinical Delivery in Cardiometabolic Health, Exploratory Medicine and Pharmacology at Eli Lilly and Company. Previously, Yan held roles including Postdoctoral Fellow at the U.S. FDA’s National Center for Toxicological Research, where they contributed to projects on the genotoxicity of tobacco products and the assessment of nanomaterials. Yan also worked as a Study Director at Covance and served in various capacities at Eli Lilly from 2014 to 2021, including as a Consultant in Clinical Program Operations. They earned a Ph.D. in Pharmacology/Toxicology from the Shanghai Institute of Materia Medica in 2010.
This person is not in any teams
This person is not in any offices